AP-2α and YY1's Role in Breast Cancer
Author Information
Author(s): Allouche Abdelkader, Nolens Gregory, Tancredi Annalisa, Delacroix Laurence, Mardaga Julie, Fridman Viviana, Winkler Rosita, Boniver Jacques, Delvenne Philippe, Begon Dominique Y
Primary Institution: University of Liege
Hypothesis
The study investigates the relationship between AP-2α, YY1 transcription factors, and ERBB2 gene overexpression in breast tumors.
Conclusion
AP-2α and YY1 transcription factors are involved in the overexpression of the ERBB2 oncogene in breast tumors.
Supporting Evidence
- ERBB2 gene amplification was found in 11 cases of breast cancer.
- High levels of AP-2α and YY1 were associated with ERBB2 overexpression.
- Transfection of siRNAs targeting AP-2α and YY1 reduced ERBB2 expression in vitro.
- A significant correlation was observed between AP-2α and YY1 levels in breast tumors.
Takeaway
This study found that two proteins, AP-2α and YY1, help make a cancer gene called ERBB2 too active in breast tumors.
Methodology
The study analyzed protein levels in breast tumors using immunohistochemistry and assessed gene amplification with fluorescent in situ hybridization.
Limitations
The study had a relatively small sample size and focused only on specific transcription factors.
Participant Demographics
Patients diagnosed with breast cancer between 2002 and 2004, mean age 61.9 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website